Cancer Research Targets  Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gong, J.
Right arrow Articles by Brattain, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gong, J.
Right arrow Articles by Brattain, M. G.
[Cancer Research 63, 3340-3346, June 15, 2003]
© 2003 American Association for Cancer Research


Molecular Biology and Genetics

Transforming Growth Factor ß1 Increases the Stability of p21/WAF1/CIP1 Protein and Inhibits CDK2 Kinase Activity in Human Colon Carcinoma FET Cells1

JianGen Gong2, Sudhakar Ammanamanchi2, Tien C. Ko and Michael G. Brattain3

Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York 14263 [S. A., M. G. B.]; Department of Biochemistry and Molecular Biology, Medical College of Ohio, Toledo, Ohio 43614 [J. G.]; and Department of Surgery, The University of Texas Medical Branch, Galveston, Texas 77555 [T. C. K.]

We examined transforming growth factor-ß1 (TGF-ß1) effects on cell cycle progression of human colon carcinoma FET cells. TGF-ß1 inhibited DNA synthesis and cyclin-dependent kinase (CDK) activity after release from growth arrest in association with induction of the p21 CDK inhibitor, whereas cyclins, CDKs, and p27 protein levels remained relatively unchanged. The decrease in CDK2 kinase activity was the result of increased p21 association with cyclin A-CDK2 and cyclin E-CDK2. TGF-ß1 treatment in late G1 showed reduced induction of p21 protein levels in association with increased DNA synthesis. Consequently, p21 induction in early G1 is critical for TGF-ß1 inhibition of CDK2 kinase activity. Although TGF-ß1 treatments in late G1 failed to induce p21 protein, p21 mRNA induction was observed in late G1 and in S phase. Further analysis showed that TGF-ß1 treatment in early G1 increases p21 protein stability throughout the G1 and S phases of the cell cycle. Our results demonstrate that TGF-ß1 stimulation of p21 is regulated at the posttranscriptional and transcriptional levels. This is a novel mechanism of TGF-ß1 inhibition requiring early G1 induction and stabilization of p21 protein, which binds to and inhibits cyclin E-CDK2 and cyclin A-CDK2 kinase activity rather than direct modulation of cyclin or CDK protein levels as seen in other systems.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
D.-S. Lee, J.-T. Park, H.-M. Kim, J. S. Ko, H.-H. Son, R. M. Gronostajski, M.-I. Cho, P.-H. Choung, and J.-C. Park
Nuclear Factor I-C Is Essential for Odontogenic Cell Proliferation and Odontoblast Differentiation during Tooth Root Development
J. Biol. Chem., June 19, 2009; 284(25): 17293 - 17303.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Wang, L. Yang, J. Yang, K. Kuropatwinski, W. Wang, X.-Q. Liu, J. Hauser, and M. G. Brattain
Transforming Growth Factor {beta} Induces Apoptosis through Repressing the Phosphoinositide 3-Kinase/AKT/Survivin Pathway in Colon Cancer Cells
Cancer Res., May 1, 2008; 68(9): 3152 - 3160.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K.-W. Lee, H. J. Kim, Y. S. Lee, H.-J. Park, J.-W. Choi, J. Ha, and K.-T. Lee
Acteoside inhibits human promyelocytic HL-60 leukemia cell proliferation via inducing cell cycle arrest at G0/G1 phase and differentiation into monocyte
Carcinogenesis, September 1, 2007; 28(9): 1928 - 1936.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Aneja, A. M. Ghaleb, J. Zhou, V. W. Yang, and H. C. Joshi
p53 and p21 Determine the Sensitivity of Noscapine-Induced Apoptosis in Colon Cancer Cells
Cancer Res., April 15, 2007; 67(8): 3862 - 3870.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
C.-C. Yen, Y.-H. Huang, C.-Y. Liao, C.-J. Liao, W.-L. Cheng, W.-J. Chen, and K.-H. Lin
Mediation of the inhibitory effect of thyroid hormone on proliferation of hepatoma cells by transforming growth factor-beta
J. Mol. Endocrinol., February 1, 2006; 36(1): 9 - 21.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. Levy and C. S. Hill
Smad4 Dependency Defines Two Classes of Transforming Growth Factor {beta} (TGF-{beta}) Target Genes and Distinguishes TGF-{beta}-Induced Epithelial-Mesenchymal Transition from Its Antiproliferative and Migratory Responses
Mol. Cell. Biol., September 15, 2005; 25(18): 8108 - 8125.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. Moustakas and C.-H. Heldin
Non-Smad TGF-{beta} signals
J. Cell Sci., August 15, 2005; 118(16): 3573 - 3584.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Saika, Y. Muragaki, Y. Okada, T. Miyamoto, Y. Ohnishi, A. Ooshima, and W. W.-Y. Kao
Sonic Hedgehog Expression and Role in Healing Corneal Epithelium
Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2577 - 2585.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Ammanamanchi, M. P. M. Tillekeratne, T. C. Ko, and M. G. Brattain
Endogenous Control of Cell Cycle Progression by Autocrine Transforming Growth Factor {beta} in Breast Cancer Cells
Cancer Res., April 1, 2004; 64(7): 2509 - 2515.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.